Author

Leejung Choi

Observed name: Choi, Leejung

Institution: Syneos Health (South Korea)

Observed institution: Syneos Health (South Korea)

ORCID: 0000-0002-5599-4554

Observed ORCID: 0000-0002-5599-4554

OpenAlex ID: A5062283757

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate

2023 · Eliel Nham, Hye Seong, et al. · Human Vaccines & Immunotherapeutics · 9

Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea

2022 · Jung-Yoon Kang, Leejung Choi, et al. · Journal of Bone Metabolism · 9

1168. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate

2023 · Eliel Nham, Hye Seong, et al. · Open Forum Infectious Diseases

Matching-adjusted Indirect Comparison (MAIC) of Tralokinumab Versus Dupilumab for the Treatment of Moderate to Severe Adult Atopic Dermatitis

2023 · Taekyung Kim, Keun Soo Shin, et al. · Korean Journal of Clinical Pharmacy

Works count: 5

Citation count: 18

H-index: 2

I10-index: